{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:00:59Z","timestamp":1774522859830,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stroke is one of the most common causes of death and permanent neurological disabilities worldwide yet neuroprotective or regenerative therapies do not exist. Genetically modified neural stem cells (NSC) could help overcome key limitations of na\u00efve or unmodified NSCs and improve therapeutic efficacy. The aim of this systematic review and meta-analysis is to evaluate existing preclinical literature using animal models to compare the therapeutic effects of genetically modified NSCs for stroke compared to na\u00efve NSCs or vehicle control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Controlled studies investigating genetically modified NSC therapy using animal models of stroke were identified using PUBMED, Scopus and the Chinese National Knowledge Infrastructure (CNKI). Primary outcomes were lesion volume reduction and neurological functional recovery measured via Neurological Severity Score (NSS). Data for meta-analysis were synthesized and expressed as standardised mean difference (SMD) with 95% confidence intervals (CI) using inverse variance and a random effects model. Our secondary outcomes of interest included modified NSC survival, NSC differentiation into neurons, endogenous neural integration, anti-inflammatory effects and migratory capacities. Twenty-nine studies were included for systematic review, and eighteen studies were included for meta-analysis. Genetically modified NSCs significantly reduced lesion volume when compared to both na\u00efve NSCs (SMD 1.07; 95% CI: [0.70, 1.43]; p\u2009&lt;\u20090.00001) and vehicle\/injury control (SMD 4.60; 95% CI: [2.69, 6.51]; p\u2009&lt;\u20090.00001), and also significantly improved neurological functional recovery compared to both na\u00efve NSCs (SMD 2.75; 95% CI: [0.34, 5.16]; p\u2009=\u20090.03) and vehicle\/injury control (SMD 4.28; 95% CI: [0.64, 7.93]; p\u2009=\u20090.02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Existing preclinical literature suggests that genetically modified NSCs have the potential to improve therapeutic efficacy of NSCs. However, our systematic review revealed the field lacks uniformity in outcomes measured, an optimised protocol for cell therapy and absence of large animal model studies, all of which pose significant barriers to clinical translation and must be addressed for the field to progress. While we were unable to identify a clear candidate gene, our review highlights the potential for genetically modified NSCs as a future adjunct neuroprotective therapy for stroke and warrants further research in this area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-025-07603-y","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:24:30Z","timestamp":1771496670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic efficacy of genetically engineered neural stem cells in cerebral ischemia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Sandra","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricki Anne","family":"Solis Marzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Razak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie H. Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8421-461X","authenticated-orcid":false,"given":"Courtney A.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"10","key":"7603_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","volume":"23","author":"VL Feigin","year":"2024","unstructured":"Feigin VL, Abate MD, Abate YH, Abd ElHafeez S, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of stroke and its risk factors, 1990-2021. A systematic analysis for the Global burden of disease study 2021. The Lancet Neurol. 2024;23(10):973\u20131003.","journal-title":"The Lancet Neurol"},{"key":"7603_CR2","doi-asserted-by":"crossref","unstructured":"Anthony S, Cabantan D, Monsour M, Borlongan CV. Neuroinflammation, stem cells, and Stroke. Stroke. 2022;53(5):1460\u201372.","DOI":"10.1161\/STROKEAHA.121.036948"},{"key":"7603_CR3","unstructured":"MartInez-Coria H, Arrieta-Cruz I, Cruz ME, L\u00f3pez-Vald\u00e9s HE. Physiopathology of ischemic stroke and its modulation using memantine: evidence from preclinical stroke. (1673\u20135374 (Print))."},{"key":"7603_CR4","unstructured":"Mao JH, Xu Y, Li BW, Yang YL, Peng Y, Zhi F. Microglia polarization in ischemic stroke: complex mechanisms and therapeutic interventions. (2542-5641 (Electronic))."},{"key":"7603_CR5","doi-asserted-by":"crossref","unstructured":"Woodruff TM, Thundyil J, Tang S-C, Sobey CG, Taylor SM, Arumugam TV. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011;6(1):11.","DOI":"10.1186\/1750-1326-6-11"},{"key":"7603_CR6","doi-asserted-by":"publisher","unstructured":"Jurcau A-O, Simion A. Neuroinflammation in cerebral ischemia and ischemia\/Reperfusion injuries: from Pathophysiology to therapeutic strategies. LID -. https:\/\/doi.org\/10.3390\/ijms23010014 - 14. (1422-0067 (Electronic)).","DOI":"10.3390\/ijms23010014"},{"key":"7603_CR7","unstructured":"Spronk E, Sykes G, Falcione S, Munsterman D, Joy T, Kamtchum-Tatuene J, et al. Hemorrhagic Transformation in ischemic stroke and the role of Inflammation. (1664-2295 (Print))."},{"key":"7603_CR8","unstructured":"Liu Q, Shi KA-O, Wang YA-O, Shi FA-O. Neurovascular Inflammation and complications of thrombolysis therapy in stroke. Electronic; 1524-4628."},{"key":"7603_CR9","doi-asserted-by":"publisher","unstructured":"Kov\u00e1cs KB, Bencs V, Hud\u00e1k L, Ol\u00e1h L, Csiba L. Hemorrhagic Transformation of ischemic strokes. In: LID. https:\/\/doi.org\/10.3390\/ijms241814067 LID - 14067. (1422-0067(Electronic)).","DOI":"10.3390\/ijms241814067"},{"key":"7603_CR10","doi-asserted-by":"crossref","unstructured":"Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies. Exp Neurol. 2021;335:113518.","DOI":"10.1016\/j.expneurol.2020.113518"},{"key":"7603_CR11","doi-asserted-by":"publisher","unstructured":"Liu D-O, Bobrovskaya L, Zhou XF. Cell therapy for neurological disorders: the perspective of promising cells. LID -. https:\/\/doi.org\/10.3390\/biology10111142 . LID - 1142. (2079-7737 (Print)).","DOI":"10.3390\/biology10111142"},{"key":"7603_CR12","doi-asserted-by":"crossref","unstructured":"Tang H, Li Y, Tang W, Zhu J, Parker GC, Zhang JH. Endogenous neural stem cell-induced neurogenesis after ischemic stroke: processes for brain repair and perspectives. Transl Stroke Res. 2023;14(3):297\u2013303.","DOI":"10.1007\/s12975-022-01078-5"},{"key":"7603_CR13","doi-asserted-by":"crossref","unstructured":"Savitz SI, Parsha K. 60 - enhancing stroke recovery with cellular therapies. In: Grotta JC, Albers GW, Broderick JP, Kasner SE, Lo EH, Mendelow AD, et al. In: Stroke (Sixth Edition). editors. London: Elsevier; 2016. p. 981\u201391.","DOI":"10.1016\/B978-0-323-29544-4.00060-8"},{"issue":"3","key":"7603_CR14","doi-asserted-by":"publisher","first-page":"e01214","DOI":"10.1002\/brb3.1214","volume":"9","author":"EW Baker","year":"2019","unstructured":"Baker EW, Kinder HA, West FD. Neural stem cell therapy for stroke: a multimechanistic approach to restoring neurological function. Brain Behav. 2019;9(3):e01214.","journal-title":"Brain Behav"},{"key":"7603_CR15","doi-asserted-by":"crossref","unstructured":"Kawabori M, Shichinohe H, Kuroda S, Houkin K. Clinical trials of stem cell therapy for cerebral ischemic stroke. Int J Mol Sci [Internet]. 2020;21(19).","DOI":"10.3390\/ijms21197380"},{"issue":"2","key":"7603_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/jamaneurol.2023.5200","volume":"81","author":"K Houkin","year":"2024","unstructured":"Houkin K, Osanai T, Uchiyama S, Minematsu K, Taguchi A, Maruichi K, et al. Allogeneic stem cell therapy for acute ischemic stroke: the phase 2\/3 treasure randomized clinical trial. JAMA Neurol. 2024;81(2):154\u201362.","journal-title":"JAMA Neurol"},{"issue":"1","key":"7603_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s13287-024-04089-1","volume":"15","author":"X Tang","year":"2024","unstructured":"Tang X, Deng P, Li L, He Y, Wang J, Hao D, et al. Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases. STEM Cell Res Ther. 2024;15(1):482.","journal-title":"STEM Cell Res Ther"},{"key":"7603_CR18","doi-asserted-by":"publisher","first-page":"- 2019","DOI":"10.3389\/fbioe.2019.00315","volume":"7","author":"S Motamed","year":"2019","unstructured":"Motamed S, Del Borgo MP, Zhou K, Kulkarni K, Crack PJ, Merson TD, et al. Migration and differentiation of neural stem cells diverted from the subventricular zone by an injectable self-assembling \u03b2-peptide hydrogel. Front Bioeng Biotechnol. 2019;7-2019.","journal-title":"Front Bioeng Biotechnol"},{"key":"7603_CR19","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336\u201341.","DOI":"10.1016\/j.ijsu.2010.02.007"},{"issue":"1","key":"7603_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14(1):43.","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"7603_CR21","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1046\/j.1460-9568.1998.00214.x","volume":"10","author":"G Andsberg","year":"1998","unstructured":"Andsberg G, ZKa B, Lindvall O, Mart\u00ednez-Serrano A. Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells. Eur J Neurosci. 1998;10(6):2026\u201336.","journal-title":"Eur J Neurosci"},{"key":"7603_CR22","doi-asserted-by":"crossref","unstructured":"Bernstock JD, Peruzzotti-Jametti L, Leonardi T, Vicario N, Ye D, Y-J L, et al. Sumoylation promotes survival and integration of neural stem cell grafts in ischemic stroke. eBiomedicine. 2019;42:214\u201324.","DOI":"10.1016\/j.ebiom.2019.03.035"},{"key":"7603_CR23","doi-asserted-by":"crossref","unstructured":"Chen B, Gao XQ, Yang CX, Tan SK, Sun ZL, Yan NH, et al. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res. 2009;1284:1\u201311.","DOI":"10.1016\/j.brainres.2009.05.100"},{"issue":"11","key":"7603_CR24","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1093\/brain\/awm200","volume":"130","author":"AG Dayer","year":"2007","unstructured":"Dayer AG, Jenny B, Sauvain M-O, Potter G, Salmon P, Zgraggen E, et al. Expression of FGF-2 in neural progenitor cells enhances their potential for cellular brain repair in the rodent cortex. Brain. 2007;130(11):2962\u201376.","journal-title":"Brain"},{"issue":"6","key":"7603_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/stem.46","volume":"27","author":"B Jenny","year":"2009","unstructured":"Jenny B, Kanemitsu M, Tsupykov O, Potter G, Salmon P, Zgraggen E, et al. Fibroblast growth factor-2 overexpression in transplanted neural progenitors promotes perivascular cluster formation with a neurogenic potential. STEM Cells. 2009;27(6):1309\u201317.","journal-title":"STEM Cells"},{"issue":"10","key":"7603_CR26","doi-asserted-by":"publisher","first-page":"1807591","DOI":"10.1002\/adma.201807591","volume":"31","author":"X-C Jiang","year":"2019","unstructured":"Jiang X-C, Xiang J-J, Wu H-H, Zhang T-Y, Zhang D-P, Xu Q-H, et al. Neural stem cells Transfected with reactive oxygen Species-responsive polyplexes for effective treatment of ischemic stroke. Adv Mater. 2019;31(10):1807591.","journal-title":"Adv Mater"},{"issue":"6","key":"7603_CR27","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/j.1460-9568.2007.05776.x","volume":"26","author":"M Kameda","year":"2007","unstructured":"Kameda M, Shingo T, Takahashi K, Muraoka K, Kurozumi K, Yasuhara T, et al. Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. Eur J Neurosci. 2007;26(6):1462\u201378.","journal-title":"Eur J Neurosci"},{"key":"7603_CR28","doi-asserted-by":"crossref","unstructured":"Korshunova I, Rhein S, Garc\u00eda-Gonz\u00e1lez D, St\u00f6lting I, Pfisterer U, Barta A, et al. Genetic modification increases the survival and the neuroregenerative properties of transplanted neural stem cells. JCI Insight. 2020;5(4).","DOI":"10.1172\/jci.insight.126268"},{"issue":"1","key":"7603_CR29","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1371\/journal.pone.0000156","volume":"2","author":"HJ Lee","year":"2007","unstructured":"Lee HJ, Kim KS, Park IH, Kim SU. Human neural stem cells over-expressing VEGF Provide Neuroprotection, Angiogenesis and functional recovery in Mouse stroke model. PLoS One. 2007;2(1):e156.","journal-title":"PLoS One"},{"key":"7603_CR30","doi-asserted-by":"crossref","unstructured":"Lee HJ, Kim MK, Kim HJ, Kim SU. Human neural stem cells genetically modified to overexpress Akt1 Provide neuroprotection and functional improvement in Mouse stroke model. PLoS One. 2009;4(5):e 5586.","DOI":"10.1371\/journal.pone.0005586"},{"key":"7603_CR31","doi-asserted-by":"crossref","unstructured":"Lee HJ, Lim IJ, Lee MC, Kim SU. Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res. 2010;88(15):3282\u201394.","DOI":"10.1002\/jnr.22474"},{"key":"7603_CR32","unstructured":"\u5218\u82b3, \u6bdb\u5fd7\u84c9, \u9093\u8389, \u9648\u6ce2, \u8881\u743c\u5170, \u9ad8\u5c0f\u9752. GDNF\u57fa\u56e0\u4fee\u9970\u7684NSCs\u79fb\u690d\u5bf9\u6682\u65f6\u6027\u7f3a\u8840\u6027\u8111\u5352\u4e2d\u5927\u9f20\u7684\u795e\u7ecf\u4fdd\u62a4\u4f5c\u7528\u7814\u7a76. \u4e2d\u56fd\u4e34\u5e8a\u89e3\u5256\u5b66\u6742\u5fd7. 2020;38(4):408\u201313."},{"key":"7603_CR33","doi-asserted-by":"crossref","unstructured":"Pignataro G, Studer FE, Wilz A, Simon RP, Boison D. Neuroprotection in ischemic Mouse brain induced by stem cell-derived brain implants. J Cereb Blood Flow Metab. 2007;27(5):919\u201327.","DOI":"10.1038\/sj.jcbfm.9600422"},{"key":"7603_CR34","doi-asserted-by":"crossref","unstructured":"Sakata H, Niizuma KF, Wakai T, Wakai TF, Narasimhan P, Narasimhan PF, Maier CM, Maier CF, Chan PH, Chan PH. Neural stem cells genetically modified to overexpress cu\/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice. 2012;(1524\u20134628 (Electronic)).","DOI":"10.1161\/STROKEAHA.112.656900"},{"key":"7603_CR35","unstructured":"\u5b8b\u5dcd, \u6768\u51c0\u677e, \u5f6d\u95f0\u6885, \u8881\u6b23, \u738b\u7f61. \u8111\u6e90\u6027\u795e\u7ecf\u8425\u517b\u56e0\u5b50\u57fa\u56e0\u4fee\u9970\u7684\u795e\u7ecf\u5e72\u7ec6\u80de\u5bf9\u8111\u5352\u4e2d\u5927\u9f20\u8ba4\u77e5\u529f\u80fd\u7684\u673a\u5236\u7814\u7a76. \u8111\u4e0e\u795e\u7ecf\u75be\u75c5\u6742\u5fd7. 2024;32(3):193\u201398."},{"key":"7603_CR36","doi-asserted-by":"crossref","unstructured":"Tang X, Wu L, Zhu J, Xu M, Li S, Zeng G, et al. GABAergic neurons differentiated from BDNF- and Dlx2-modified neural stem cells restore disrupted neural circuits in brainstem stroke. STEM Cell Res Ther. 2023;14(1):170.","DOI":"10.1186\/s13287-023-03378-5"},{"key":"7603_CR37","doi-asserted-by":"crossref","unstructured":"Tian L, Zhu W, Liu Y, Gong Y, Lv A, Wang Z, et al. Neural stem cells Transfected with leukemia inhibitory factor promote Neuroprotection in a Rat model of cerebral ischemia. Neurosci Bull. 2019;35(5):901\u201308.","DOI":"10.1007\/s12264-019-00405-5"},{"issue":"3","key":"7603_CR38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/jcbfm.2013.215","volume":"34","author":"T Wakai","year":"2013","unstructured":"Wakai T, Sakata H, Narasimhan P, Yoshioka H, Kinouchi H, Chan PH. Transplantation of neural stem cells that overexpress Sod1 enhances amelioration of Intracerebral hemorrhage in mice. J Cereb Blood Flow Metab. 2013;34(3):441\u201349.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"7603_CR39","doi-asserted-by":"publisher","first-page":"9621","DOI":"10.1038\/srep09621","volume":"5","author":"J Wang","year":"2015","unstructured":"Wang J, Xia J, Zhang F, Shi Y, Wu Y, Pu H, et al. Galectin-1-secreting neural stem cells elicit long-term neuroprotection against ischemic brain injury. Sci Rep. 2015;5(1):9621.","journal-title":"Sci Rep"},{"key":"7603_CR40","doi-asserted-by":"crossref","unstructured":"Wu W, Chen X, Hu C, Li J, Yu Z, Cai W. Transplantation of neural stem cells expressing hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) improves behavioral recovery in a rat stroke model. J Clin Neurosci. 2010;17(1):92\u201395.","DOI":"10.1016\/j.jocn.2009.03.039"},{"key":"7603_CR41","unstructured":"\u5434\u4e2d\u534e. \u8111\u5916\u6e90\u6027\u795e\u7ecf\u56e0\u5b50\u57fa\u56e0\u4fee\u9970\u795e\u7ecf\u5e72\u7ec6\u80de\u5bf9\u8111\u5352\u4e2d\u7684\u795e\u7ecf\u4fdd\u62a4\u673a\u5236. \u4e2d\u56fd\u7ec4\u7ec7\u5de5\u7a0b\u7814\u7a76. 2015;19(45):7331\u201336."},{"issue":"1","key":"7603_CR42","first-page":"8739730","volume":"2019","author":"P Xu","year":"2019","unstructured":"Xu P, Shi X, Zhang X, Liu Q, Xie Y, Hong Y, et al. Overexpression of BRCA1 in neural stem cells enhances cell survival and functional recovery after transplantation into experimental ischemic stroke. Oxidative Med Cellular Longevity. 2019;2019(1):8739730.","journal-title":"Oxidative Med Cellular Longevity"},{"issue":"9","key":"7603_CR43","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.4103\/1673-5374.191220","volume":"11","author":"Y Yao","year":"2016","unstructured":"Yao Y, Zheng X-R, Zhang S-S, Wang X, Yu X-H, Tan J-L, et al. Transplantation of vascular endothelial growth factor-modified neural stem\/progenitor cells promotes the recovery of neurological function following hypoxic-ischemic brain damage. Neural Regener Res. 2016;11(9):1456\u201363.","journal-title":"Neural Regener Res"},{"issue":"1","key":"7603_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000486226","volume":"45","author":"Q Ye","year":"2017","unstructured":"Ye Q, Wu Y, Wu J, Zou S, Al-Zaazaai Ali A, Zhang H, et al. Neural stem cells expressing bFGF reduce brain damage and restore sensorimotor function after neonatal hypoxia-ischemia. Cellular Physiol Biochem. 2017;45(1):108\u201318.","journal-title":"Cellular Physiol Biochem"},{"key":"7603_CR45","doi-asserted-by":"crossref","unstructured":"Zhang J-J, Zhu J-J, Hu Y-B, Xiang G-H, Deng L-C, Wu F-Z, et al. Transplantation of bFGF-expressing neural stem cells promotes cell migration and functional recovery in rat brain after transient ischemic stroke. Oncotarget. 2017, 60;8, No.","DOI":"10.18632\/oncotarget.22155"},{"issue":"3","key":"7603_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neulet.2008.08.049","volume":"444","author":"Z Z-H","year":"2008","unstructured":"Zhang Z-H, Wang R-Z, Wang R-Z, Li G-l, Wei J-J, Li Z-J, et al. Transplantation of neural stem cells modified by human neurotrophin-3 promotes functional recovery after transient focal cerebral ischemia in rats. Neurosci Lett. 2008;444(3):227\u201330.","journal-title":"Neurosci Lett"},{"issue":"7","key":"7603_CR47","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.02.034","volume":"26","author":"Z J-D","year":"2017","unstructured":"Zhu J-D, Wang J-J, Ge G, Kang C-S. Effects of Noggin-Transfected neural stem cells on neural functional recovery and underlying mechanism in rats with cerebral ischemia Reperfusion Injury. J Stroke And Cerebrovascular Dis. 2017;26(7):1547\u201359.","journal-title":"J Stroke And Cerebrovascular Dis"},{"key":"7603_CR48","doi-asserted-by":"crossref","unstructured":"Zhu J, Zhao Y, Chen S, Zhang W, Lou L, Jin X. Functional recovery after transplantation of neural stem cells modified by brain-derived neurotrophic factor in rats with cerebral ischaemia. J Int Med Res. 2011;39(2):488\u201398.","DOI":"10.1177\/147323001103900216"},{"key":"7603_CR49","doi-asserted-by":"publisher","first-page":"137668","DOI":"10.1016\/j.neulet.2024.137668","volume":"824","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Liu R, Zhao X, Kang C, Yang D, Ge G. VEGF overexpression in transplanted NSCs promote recovery of neurological function in rats with cerebral ischemia by modulating the wnt signal transduction pathway. Neurosci Lett. 2024;824:137668.","journal-title":"Neurosci Lett"},{"issue":"1","key":"7603_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","volume":"378","author":"G Nogueira Raul","year":"2018","unstructured":"Nogueira Raul G, Jadhav Ashutosh P, Haussen Diogo C, Bonafe A, Budzik Ronald F, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11\u201321.","journal-title":"N Engl J Med"},{"key":"7603_CR51","doi-asserted-by":"crossref","unstructured":"Santana Baskar P, Cordato D, Wardman D, Bhaskar S. In-hospital acute stroke workflow in acute stroke - Systems-based approaches. Acta Neurologica Scandinavica. 2021;143(2):111\u201320.","DOI":"10.1111\/ane.13343"},{"key":"7603_CR52","doi-asserted-by":"crossref","unstructured":"Sun Y, Jiang X, Gao J. Stem cell-based ischemic stroke therapy: novel modifications and clinical challenges. Asian J Pharm Sci. 2024;19(1):100867.","DOI":"10.1016\/j.ajps.2023.100867"},{"key":"7603_CR53","doi-asserted-by":"crossref","unstructured":"Amer MH, Rose FRAJ, Shakesheff KM, Modo M, White LJ. Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges. npj regenerative Medicine. 2017;2(1):23.","DOI":"10.1038\/s41536-017-0028-x"},{"key":"7603_CR54","unstructured":"Foundation S. Australian and New Zealand living clinical Guidelines for stroke Management, stroke Foundation; Available from: https:\/\/informme.org.au\/en\/Guidelines\/Clinical-Guidelines-for-Stroke-Management."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07603-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:13:05Z","timestamp":1774519985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07603-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7603"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07603-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}